APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rhizoma Gastrodiae Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rhizoma Gastrodiae Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025182 pages

Choose your research edition.

Industry ResearchRhizoma Gastrodiae Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Rhizoma Gastrodiae Tablets Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Rhizoma Gastrodiae Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rhizoma Gastrodiae Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Rhizoma Gastrodiae Tablets Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Rhizoma Gastrodiae Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Rhizoma Gastrodiae Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rhizoma Gastrodiae Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rhizoma Gastrodiae Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rhizoma Gastrodiae Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rhizoma Gastrodiae Tablets include Zhaotong Huacheng Pharmaceutical, Taiji Group Sichuan Mianyang Pharmaceutical, Shaanxi Tianyang Pharmaceutical, Tsumura & Co., Lanzhou Foci Pharmaceutical, Guizhou Bailing, Guangxi Chanfang Pharmaceutical, Guangdong Luofushan National Pharmaceutical and Tongrentang Chinese Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rhizoma Gastrodiae Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rhizoma Gastrodiae Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rhizoma Gastrodiae Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rhizoma Gastrodiae Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Rhizoma Gastrodiae Tablets Segment by Company

Zhaotong Huacheng Pharmaceutical

Taiji Group Sichuan Mianyang Pharmaceutical

Shaanxi Tianyang Pharmaceutical

Tsumura & Co.

Lanzhou Foci Pharmaceutical

Guizhou Bailing

Guangxi Chanfang Pharmaceutical

Guangdong Luofushan National Pharmaceutical

Tongrentang Chinese Medicine

Rhizoma Gastrodiae Tablets Segment by Type

Gastrodia elata f.glauca

G.elata.BI.f elata

Other

Rhizoma Gastrodiae Tablets Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Rhizoma Gastrodiae Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rhizoma Gastrodiae Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rhizoma Gastrodiae Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rhizoma Gastrodiae Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rhizoma Gastrodiae Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rhizoma Gastrodiae Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rhizoma Gastrodiae Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rhizoma Gastrodiae Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rhizoma Gastrodiae Tablets Industry Trends Table 2. Rhizoma Gastrodiae Tablets Industry Drivers Table 3. Rhizoma Gastrodiae Tablets Industry Opportunities and Challenges Table 4. Rhizoma Gastrodiae Tablets Industry Restraints Table 5. Global Rhizoma Gastrodiae Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rhizoma Gastrodiae Tablets Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Rhizoma Gastrodiae Tablets Sales Market Share by Manufacturers Table 9. Global Rhizoma Gastrodiae Tablets Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Rhizoma Gastrodiae Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rhizoma Gastrodiae Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rhizoma Gastrodiae Tablets Manufacturers, Product Type & Application Table 13. Global Rhizoma Gastrodiae Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rhizoma Gastrodiae Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gastrodia elata f.glauca Table 17. Major Manufacturers of G.elata.BI.f elata Table 18. Major Manufacturers of Other Table 19. Global Rhizoma Gastrodiae Tablets Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Rhizoma Gastrodiae Tablets Sales by Type (2021-2026) & (k units) Table 21. Global Rhizoma Gastrodiae Tablets Sales by Type (2027-2032) & (k units) Table 22. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2021-2026) Table 23. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2027-2032) Table 24. Global Rhizoma Gastrodiae Tablets Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Rhizoma Gastrodiae Tablets Revenue by Type (2021-2026) & (k units) Table 26. Global Rhizoma Gastrodiae Tablets Revenue by Type (2027-2032) & (k units) Table 27. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2021-2026) Table 28. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Pharmacies Table 30. Major Manufacturers of Online Pharmacies Table 31. Major Manufacturers of Retail Pharmacies Table 32. Global Rhizoma Gastrodiae Tablets Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Rhizoma Gastrodiae Tablets Sales by Application (2021-2026) & (k units) Table 34. Global Rhizoma Gastrodiae Tablets Sales by Application (2027-2032) & (k units) Table 35. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2021-2026) Table 36. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2027-2032) Table 37. Global Rhizoma Gastrodiae Tablets Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Rhizoma Gastrodiae Tablets Revenue by Application (2021-2026) & (k units) Table 39. Global Rhizoma Gastrodiae Tablets Revenue by Application (2027-2032) & (k units) Table 40. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2021-2026) Table 41. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2027-2032) Table 42. Global Rhizoma Gastrodiae Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Rhizoma Gastrodiae Tablets Sales by Region (2021-2026) & (k units) Table 44. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2021-2026) Table 45. Global Rhizoma Gastrodiae Tablets Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Rhizoma Gastrodiae Tablets Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Rhizoma Gastrodiae Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 49. North America Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 50. Europe Rhizoma Gastrodiae Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 52. Europe Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Rhizoma Gastrodiae Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Rhizoma Gastrodiae Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 59. Global Rhizoma Gastrodiae Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Rhizoma Gastrodiae Tablets Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Rhizoma Gastrodiae Tablets Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2021-2026) Table 63. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2027-2032) Table 64. Zhaotong Huacheng Pharmaceutical Company Information Table 65. Zhaotong Huacheng Pharmaceutical Business Overview Table 66. Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 68. Zhaotong Huacheng Pharmaceutical Recent Development Table 69. Taiji Group Sichuan Mianyang Pharmaceutical Company Information Table 70. Taiji Group Sichuan Mianyang Pharmaceutical Business Overview Table 71. Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 73. Taiji Group Sichuan Mianyang Pharmaceutical Recent Development Table 74. Shaanxi Tianyang Pharmaceutical Company Information Table 75. Shaanxi Tianyang Pharmaceutical Business Overview Table 76. Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 78. Shaanxi Tianyang Pharmaceutical Recent Development Table 79. Tsumura & Co. Company Information Table 80. Tsumura & Co. Business Overview Table 81. Tsumura & Co. Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Tsumura & Co. Rhizoma Gastrodiae Tablets Product Portfolio Table 83. Tsumura & Co. Recent Development Table 84. Lanzhou Foci Pharmaceutical Company Information Table 85. Lanzhou Foci Pharmaceutical Business Overview Table 86. Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 88. Lanzhou Foci Pharmaceutical Recent Development Table 89. Guizhou Bailing Company Information Table 90. Guizhou Bailing Business Overview Table 91. Guizhou Bailing Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Guizhou Bailing Rhizoma Gastrodiae Tablets Product Portfolio Table 93. Guizhou Bailing Recent Development Table 94. Guangxi Chanfang Pharmaceutical Company Information Table 95. Guangxi Chanfang Pharmaceutical Business Overview Table 96. Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 98. Guangxi Chanfang Pharmaceutical Recent Development Table 99. Guangdong Luofushan National Pharmaceutical Company Information Table 100. Guangdong Luofushan National Pharmaceutical Business Overview Table 101. Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 103. Guangdong Luofushan National Pharmaceutical Recent Development Table 104. Tongrentang Chinese Medicine Company Information Table 105. Tongrentang Chinese Medicine Business Overview Table 106. Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product Portfolio Table 108. Tongrentang Chinese Medicine Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Rhizoma Gastrodiae Tablets Distributors List Table 112. Rhizoma Gastrodiae Tablets Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Rhizoma Gastrodiae Tablets Product Image Figure 2. Global Rhizoma Gastrodiae Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rhizoma Gastrodiae Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Rhizoma Gastrodiae Tablets Sales (2021-2032) & (k units) Figure 5. Global Rhizoma Gastrodiae Tablets Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Rhizoma Gastrodiae Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gastrodia elata f.glauca Image Figure 9. G.elata.BI.f elata Image Figure 10. Other Image Figure 11. Global Rhizoma Gastrodiae Tablets Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Rhizoma Gastrodiae Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2021-2032) Figure 14. Global Rhizoma Gastrodiae Tablets Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Rhizoma Gastrodiae Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Retail Pharmacies Image Figure 20. Global Rhizoma Gastrodiae Tablets Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Rhizoma Gastrodiae Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2021-2032) Figure 23. Global Rhizoma Gastrodiae Tablets Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Rhizoma Gastrodiae Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2021-2032) Figure 26. North America Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Rhizoma Gastrodiae Tablets Sales Market Share by Country (2021-2032) Figure 28. U.S. Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Rhizoma Gastrodiae Tablets Sales Market Share by Country (2021-2032) Figure 33. Germany Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Rhizoma Gastrodiae Tablets Sales Market Share by Country (2021-2032) Figure 40. China Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Rhizoma Gastrodiae Tablets Sales Market Share by Country (2021-2032) Figure 48. Brazil Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Rhizoma Gastrodiae Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Rhizoma Gastrodiae Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Figure 59. North America Rhizoma Gastrodiae Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Europe Rhizoma Gastrodiae Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Rhizoma Gastrodiae Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Rhizoma Gastrodiae Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Rhizoma Gastrodiae Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Rhizoma Gastrodiae Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gastrodia elata f.glauca
  • G.elata.BI.f elata
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Zhaotong Huacheng Pharmaceutical
  • Taiji Group Sichuan Mianyang Pharmaceutical
  • Shaanxi Tianyang Pharmaceutical
  • Tsumura & Co.
  • Lanzhou Foci Pharmaceutical
  • Guizhou Bailing
  • Guangxi Chanfang Pharmaceutical
  • Guangdong Luofushan National Pharmaceutical
  • Tongrentang Chinese Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rhizoma Gastrodiae Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rhizoma Gastrodiae Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rhizoma Gastrodiae Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rhizoma Gastrodiae Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rhizoma Gastrodiae Tablets Market Dynamics
  1. 2.1 Rhizoma Gastrodiae Tablets Industry Trends
  2. 2.2 Rhizoma Gastrodiae Tablets Industry Drivers
  3. 2.3 Rhizoma Gastrodiae Tablets Industry Opportunities and Challenges
  4. 2.4 Rhizoma Gastrodiae Tablets Industry Restraints
3 Rhizoma Gastrodiae Tablets Market by Manufacturers
  1. 3.1 Global Rhizoma Gastrodiae Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rhizoma Gastrodiae Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rhizoma Gastrodiae Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rhizoma Gastrodiae Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rhizoma Gastrodiae Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rhizoma Gastrodiae Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Rhizoma Gastrodiae Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rhizoma Gastrodiae Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rhizoma Gastrodiae Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rhizoma Gastrodiae Tablets Tier 1, Tier 2, and Tier 3
4 Rhizoma Gastrodiae Tablets Market by Type
  1. 4.1 Rhizoma Gastrodiae Tablets Type Introduction
  2. 4.1.1 Gastrodia elata f.glauca
  3. 4.1.2 G.elata.BI.f elata
  4. 4.1.3 Other
  5. 4.2 Global Rhizoma Gastrodiae Tablets Sales by Type
  6. 4.2.1 Global Rhizoma Gastrodiae Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Rhizoma Gastrodiae Tablets Sales by Type (2021-2032)
  8. 4.2.3 Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2021-2032)
  9. 4.3 Global Rhizoma Gastrodiae Tablets Revenue by Type
  10. 4.3.1 Global Rhizoma Gastrodiae Tablets Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Rhizoma Gastrodiae Tablets Revenue by Type (2021-2032)
  12. 4.3.3 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2021-2032)
5 Rhizoma Gastrodiae Tablets Market by Application
  1. 5.1 Rhizoma Gastrodiae Tablets Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Rhizoma Gastrodiae Tablets Sales by Application
  6. 5.2.1 Global Rhizoma Gastrodiae Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rhizoma Gastrodiae Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Rhizoma Gastrodiae Tablets Revenue by Application
  10. 5.3.1 Global Rhizoma Gastrodiae Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rhizoma Gastrodiae Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2021-2032)
6 Global Rhizoma Gastrodiae Tablets Sales by Region
  1. 6.1 Global Rhizoma Gastrodiae Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rhizoma Gastrodiae Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Rhizoma Gastrodiae Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Rhizoma Gastrodiae Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rhizoma Gastrodiae Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rhizoma Gastrodiae Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rhizoma Gastrodiae Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rhizoma Gastrodiae Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rhizoma Gastrodiae Tablets Revenue by Region
  1. 7.1 Global Rhizoma Gastrodiae Tablets Revenue by Region
  2. 7.1.1 Global Rhizoma Gastrodiae Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rhizoma Gastrodiae Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Rhizoma Gastrodiae Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rhizoma Gastrodiae Tablets Revenue (2021-2032)
  8. 7.2.2 North America Rhizoma Gastrodiae Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rhizoma Gastrodiae Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Rhizoma Gastrodiae Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rhizoma Gastrodiae Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rhizoma Gastrodiae Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rhizoma Gastrodiae Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rhizoma Gastrodiae Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhaotong Huacheng Pharmaceutical
  2. 8.1.1 Zhaotong Huacheng Pharmaceutical Company Information
  3. 8.1.2 Zhaotong Huacheng Pharmaceutical Business Overview
  4. 8.1.3 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  6. 8.1.5 Zhaotong Huacheng Pharmaceutical Recent Developments
  7. 8.2 Taiji Group Sichuan Mianyang Pharmaceutical
  8. 8.2.1 Taiji Group Sichuan Mianyang Pharmaceutical Company Information
  9. 8.2.2 Taiji Group Sichuan Mianyang Pharmaceutical Business Overview
  10. 8.2.3 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  12. 8.2.5 Taiji Group Sichuan Mianyang Pharmaceutical Recent Developments
  13. 8.3 Shaanxi Tianyang Pharmaceutical
  14. 8.3.1 Shaanxi Tianyang Pharmaceutical Company Information
  15. 8.3.2 Shaanxi Tianyang Pharmaceutical Business Overview
  16. 8.3.3 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  18. 8.3.5 Shaanxi Tianyang Pharmaceutical Recent Developments
  19. 8.4 Tsumura & Co.
  20. 8.4.1 Tsumura & Co. Company Information
  21. 8.4.2 Tsumura & Co. Business Overview
  22. 8.4.3 Tsumura & Co. Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tsumura & Co. Rhizoma Gastrodiae Tablets Product Portfolio
  24. 8.4.5 Tsumura & Co. Recent Developments
  25. 8.5 Lanzhou Foci Pharmaceutical
  26. 8.5.1 Lanzhou Foci Pharmaceutical Company Information
  27. 8.5.2 Lanzhou Foci Pharmaceutical Business Overview
  28. 8.5.3 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  30. 8.5.5 Lanzhou Foci Pharmaceutical Recent Developments
  31. 8.6 Guizhou Bailing
  32. 8.6.1 Guizhou Bailing Company Information
  33. 8.6.2 Guizhou Bailing Business Overview
  34. 8.6.3 Guizhou Bailing Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guizhou Bailing Rhizoma Gastrodiae Tablets Product Portfolio
  36. 8.6.5 Guizhou Bailing Recent Developments
  37. 8.7 Guangxi Chanfang Pharmaceutical
  38. 8.7.1 Guangxi Chanfang Pharmaceutical Company Information
  39. 8.7.2 Guangxi Chanfang Pharmaceutical Business Overview
  40. 8.7.3 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  42. 8.7.5 Guangxi Chanfang Pharmaceutical Recent Developments
  43. 8.8 Guangdong Luofushan National Pharmaceutical
  44. 8.8.1 Guangdong Luofushan National Pharmaceutical Company Information
  45. 8.8.2 Guangdong Luofushan National Pharmaceutical Business Overview
  46. 8.8.3 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  48. 8.8.5 Guangdong Luofushan National Pharmaceutical Recent Developments
  49. 8.9 Tongrentang Chinese Medicine
  50. 8.9.1 Tongrentang Chinese Medicine Company Information
  51. 8.9.2 Tongrentang Chinese Medicine Business Overview
  52. 8.9.3 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product Portfolio
  54. 8.9.5 Tongrentang Chinese Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rhizoma Gastrodiae Tablets Value Chain Analysis
  2. 9.1.1 Rhizoma Gastrodiae Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rhizoma Gastrodiae Tablets Production Mode & Process
  6. 9.2 Rhizoma Gastrodiae Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rhizoma Gastrodiae Tablets Distributors
  9. 9.2.3 Rhizoma Gastrodiae Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst